Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PTE

PolarityTE (PTE) Stock Price, News & Analysis

PolarityTE logo

About PolarityTE Stock (NASDAQ:PTE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$0.57
52-Week Range
N/A
Volume
8.50 million shs
Average Volume
249,591 shs
Market Capitalization
$1.78 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter.

PTE Stock News Headlines

Regenetp Inc RGTPQ
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
RegenETP, Inc. (NJT.SG)
PolarityTE Stock (NASDAQ:PTE), Dividends
See More Headlines

PTE Stock Analysis - Frequently Asked Questions

PolarityTE, Inc. (NASDAQ:PTE) announced its earnings results on Wednesday, November, 10th. The company reported ($2.25) earnings per share for the quarter, beating the consensus estimate of ($3.00) by $0.75. The company earned $1.12 million during the quarter, compared to analysts' expectations of $0.97 million.

PolarityTE shares reverse split on the morning of Tuesday, May 17th 2022.The 1-25 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that PolarityTE investors own include Bionano Genomics (BNGO), Acasti Pharma (ACST), T2 Biosystems (TTOO), SNDL (SNDL), Zomedica (ZOM), Tonix Pharmaceuticals (TNXP) and Vaxart (VXRT).

Company Calendar

Last Earnings
11/10/2021
Today
7/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:PTE
Employees
42
Year Founded
1986

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.83 million
Pretax Margin
-11,376.71%

Debt

Sales & Book Value

Annual Sales
$810 thousand
Price / Cash Flow
N/A
Book Value
$2.30 per share
Price / Book
N/A

Miscellaneous

Free Float
6,978,000
Market Cap
$1.78 million
Optionable
Optionable
Beta
1.15

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:PTE) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners